Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 3 studies | 20% ± 5% | |
non-classical monocyte | 3 studies | 30% ± 3% |
Insufficient scRNA-seq data for expression of C5AR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 454.21 | 427 / 459 | 86% | 12.06 | 961 / 1118 |
lung | 99% | 1128.25 | 575 / 578 | 63% | 2.60 | 726 / 1155 |
kidney | 82% | 214.30 | 73 / 89 | 61% | 2.21 | 550 / 901 |
thymus | 66% | 163.41 | 428 / 653 | 63% | 1.43 | 380 / 605 |
adrenal gland | 87% | 239.87 | 224 / 258 | 33% | 0.99 | 76 / 230 |
liver | 58% | 197.69 | 131 / 226 | 62% | 2.99 | 251 / 406 |
bladder | 90% | 213.19 | 19 / 21 | 27% | 0.74 | 137 / 504 |
spleen | 100% | 2625.24 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 95% | 713.98 | 1143 / 1204 | 0% | 0 | 0 / 0 |
skin | 78% | 356.83 | 1415 / 1809 | 16% | 0.25 | 77 / 472 |
intestine | 73% | 211.34 | 706 / 966 | 20% | 0.40 | 107 / 527 |
peripheral blood | 81% | 4893.84 | 755 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 77% | 339.71 | 1027 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 48% | 121.70 | 699 / 1445 | 27% | 0.66 | 50 / 183 |
brain | 25% | 51.55 | 664 / 2642 | 46% | 0.99 | 327 / 705 |
stomach | 48% | 136.42 | 172 / 359 | 23% | 0.36 | 65 / 286 |
uterus | 42% | 93.96 | 72 / 170 | 24% | 1.27 | 109 / 459 |
pancreas | 7% | 13.64 | 24 / 328 | 55% | 1.28 | 98 / 178 |
lymph node | 0% | 0 | 0 / 0 | 62% | 1.83 | 18 / 29 |
heart | 51% | 177.75 | 436 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.66 | 21 / 45 |
ovary | 35% | 86.50 | 63 / 180 | 10% | 0.17 | 42 / 430 |
prostate | 27% | 51.53 | 66 / 245 | 1% | 0.02 | 6 / 502 |
muscle | 5% | 8.06 | 42 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032677 | Biological process | regulation of interleukin-8 production |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0006954 | Biological process | inflammatory response |
GO_0006935 | Biological process | chemotaxis |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0090024 | Biological process | negative regulation of neutrophil chemotaxis |
GO_0038178 | Biological process | complement component C5a signaling pathway |
GO_0002430 | Biological process | complement receptor mediated signaling pathway |
GO_0045177 | Cellular component | apical part of cell |
GO_0005886 | Cellular component | plasma membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0004878 | Molecular function | complement component C5a receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | C5AR2 |
Protein name | C5a anaphylatoxin chemotactic receptor 2 (Complement component 5a receptor 2) (G-protein coupled receptor 77) |
Synonyms | C5L2 GPR77 |
Description | FUNCTION: Receptor for the chemotactic and inflammatory C3a, C4a and C5a anaphylatoxin peptides and also for their dearginated forms ASP/C3adesArg, C4adesArg and C5adesArg respectively. Couples weakly to G(i)-mediated signaling pathways. . |
Accessions | Q9P296 ENST00000600626.1 ENST00000595464.3 |